|
Dual-action Sanofi asthma drug performs well in test
Allentown Morning Call Nov 11 (Reuters) – An experimental biotech drug for severe asthma from France's Sanofi, which has a location in Swiftwater, Monroe County, and its U.S. partner Regeneron has produced good results in clinical tests, suggesting its dual-action mechanism … |
View full post on asthma – Google News